TeacherMitra.com
Dictionary
Dictionary
allow_url_fopen is ENABLED
Dictionary Search
Go Find!
tarsus
Synonyms
Noun
1. skeletal structure
Usage
Tarsus (TARS) director William J. Link sells 12,500 shares in planned trades - Stock Titan
Tarsus Pharmaceuticals director Link sells $859k in stock - Investing.com
William Phd Link Sells 12,500 Shares of Tarsus Pharmaceuticals (NASDAQ:TARS) Stock - MarketBeat
Tarsus Pharmaceuticals Insider Sold Shares Worth $859,819, According to a Recent SEC Filing - marketscreener.com
Celebrating confirmations at St. Paul of Tarsus Parish in Clinton Township - Detroit Catholic
TARS (NASDAQ: TARS) reports insider sales and a 3,610-share vesting on Form 144 - Stock Titan
Tarsus Pharmaceuticals (NASDAQ:TARS) Rating Increased to Strong-Buy at Lifesci Capital - MarketBeat
Aziz A. Mottiwala to sell 4,330 shares (NASDAQ: TARS) on 03/17/2026 - Stock Titan
Tarsus Pharmaceuticals (NASDAQ: TARS) general counsel exercises 24,236 RSUs - Stock Titan
Jeffrey Farrow of Tarsus (TARS) acquires 13,042 shares through RSU settlement - Stock Titan
Tarsus (TARS) HR chief settles RSUs, holds 47,302 common shares - Stock Titan
Tarsus (NASDAQ: TARS) CCO receives 26,482 shares from RSUs - Stock Titan
Tarsus (TARS) CEO adds 66,274 shares via RSU settlement - Stock Titan
Tarsus (NASDAQ: TARS) CMO gains 2,511 shares in RSU settlement - Stock Titan
[144] Tarsus Pharmaceuticals, Inc. SEC Filing - Stock Titan
[144] Tarsus Pharmaceuticals, Inc. SEC Filing - Stock Titan
Tarsus Pharmaceuticals (TARS) files Section 144 notice to sell 12,500 shares - Stock Titan
COO at Tarsus (NASDAQ: TARS) gets 26,287 common shares from RSUs - Stock Titan
Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Capitolis Liquid Global Markets LLC - MarketBeat
Ally Bridge Group NY LLC Decreases Stake in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Integral Health Asset Management LLC Has $14.86 Million Stock Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
TARS (NASDAQ: TARS) insider files to sell 4,029 shares after vesting - Stock Titan
TARS (NASDAQ: TARS) affiliate notifies sale of 2,133 vested shares - Stock Titan
Tarsus to Participate in Upcoming Investor Conferences - Yahoo Finance
Tarsus Pharmaceuticals: Q4 Results Highlight Xdemvy Blockbuster Potential (NASDAQ:TARS) - Seeking Alpha
Tarsus Pharmaceuticals, Inc. Q4 2025 Earnings Call Summary - Yahoo Finance
Assessing Tarsus Pharmaceuticals (TARS) Valuation After Recent Mixed Share Performance - Yahoo Finance
Tarsus Reports Fourth Quarter and Full-Year 2025 Financial Results and Recent Business Achievements - Yahoo Finance
Oppenheimer Raises Its Price Target on Tarsus Pharmaceuticals, Inc. (TARS) to $105 and Maintains an Outperform Rating - Yahoo Finance
Has The Market Rerated Tarsus Pharmaceuticals (TARS) Too Cautiously After XDEMVY Adoption Headlines? - Yahoo Finance
Tarsus Reports Soaring Xdemvy Sales in Q4, Full Year - Orange County Business Journal
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q4 Loss, Beats Revenue Estimates - Yahoo Finance
A Look At Tarsus Pharmaceuticals (TARS) Valuation After Adding Former Allergan CEO David Pyott To Its Board - Yahoo Finance
LifeSci Capital Maintains Tarsus Pharmaceuticals(TARS.US) With Buy Rating, Raises Target Price to $95 - 富途牛牛
Artisan Partners Limited Partnership Boosts Stock Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Stock option and RSU grants for Tarsus (NASDAQ: TARS) executive - Stock Titan
Tarsus (TARS) COO receives new stock option and RSU equity grants - Stock Titan
Tarsus (TARS) Chief Commercial Officer receives new option and RSU grants - Stock Titan
The Bull Case For Tarsus Pharmaceuticals (TARS) Could Change Following First 2026 XDEMVY Sales Outlook - simplywall.st
While shareholders of Tarsus Pharmaceuticals (NASDAQ:TARS) are in the black over 3 years, those who bought a week ago aren't so fortunate - Yahoo Finance
Quantbot Technologies LP Reduces Holdings in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Sisecam says greenfield flat glass facility investment in Tarsus has been completed, and TR9 furnace was ignited - marketscreener.com
XDEMVY Growth And China Deal Reshape Tarsus Pharmaceuticals Investment Story - simplywall.st
Tarsus (TARS) CEO Bobak Azamian granted stock options and RSUs with multi-year vesting - Stock Titan
The Bull Case For Tarsus Pharmaceuticals (TARS) Could Change Following First 2026 XDEMVY Sales Outlook - Sahm
Does Adding Ophthalmology Veteran David Pyott to the Board Change The Bull Case For Tarsus (TARS)? - Yahoo Finance
Can Tarsus Pharmaceuticals Stock Still Offer Value After Its 48% 2025 Rally? - Yahoo Finance
Tarsus Pharmaceuticals Inc (TARS) Q3 2025 Earnings Call Highlights: Record Sales and Strategic ... - Yahoo Finance
Cherry Bekaert Bolsters Outsourced Accounting Services With Acquisition of Washington, DC-Based Firm Tarsus - PR Newswire
Tarsus Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance
Tarsus Pharmaceuticals at Barclays Conference: Strategic Growth and Challenges - Investing.com
Paul of Tarsus: Cultural Amphibian - The Catholic Thing
Tarsus Pharmaceuticals, Inc. (TARS) Expected to Beat Earnings Estimates: Can the Stock Move Higher? - Yahoo Finance
Why Tarsus Pharmaceuticals (TARS) Is Up 21.6% After Xdemvy’s Uptake and New Trial Announcements—And What's Next - Yahoo Finance
Tarsus Pharmaceuticals Inc (TARS) Q3 2025 Earnings Report Preview: What To Look For - Yahoo Finance
Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Jefferies Financial Group Inc. - MarketBeat
Stream Tarsus Pharma at TD Cowen and Barclays investor events in March - Stock Titan
Tarsus Pharmaceuticals, Inc. $TARS Shares Sold by Vanguard Group Inc. - MarketBeat
Tarsus Pharmaceuticals chief medical officer talks AI in eye care - Healthcare Brew
Citigroup Inc. Increases Position in Tarsus Pharmaceuticals, Inc. $TARS - MarketBeat
Tarsus Reports Third Quarter 2025 Financial Results and Recent Business Achievements - Yahoo Finance
Tarsus Pharmaceuticals Appoints David Pyott to its Board of Directors - VisionMonday.com
Tarsus Pharmaceuticals (TARS) Moves 10.9% Higher: Will This Strength Last? - Yahoo Finance
Tarsus to Participate in Upcoming Investor Conferences - Sahm
Tarsus Adds Former Allergan CEO to Board - Orange County Business Journal
Tarsus Pharmaceuticals Reports $451.4 Million in XDEMVY® Sales for Full-Year 2025 and Announces New Clinical Trials for Ocular Rosacea and Lyme Disease Prevention - Quiver Quantitative
Stocks With Rising Relative Strength: Tarsus Pharmaceuticals - Investor's Business Daily
A Look At Tarsus Pharmaceuticals (TARS) Valuation After 2025 Results And New Shelf Registration - simplywall.st
Tarsus Pharmaceuticals Reaches 80-Plus Relative Strength Rating Benchmark - Investor's Business Daily
Cherry Bekaert snaps up Washington-based accounting practice Tarsus - International Accounting Bulletin
Q2 net sales reach $100M for Tarsus’ XDEMVY, with pipeline potential for Lyme rooted in animal health - drugdiscoverytrends.com
Tarsus Pharmaceuticals Q4 Earnings Call Highlights - MarketBeat
A Look At Tarsus Pharmaceuticals (TARS) Valuation After 2025 Results And New Shelf Registration - Sahm
Lessons in Category Creation: In Conversation with Bobby Azamian, CEO Tarsus Pharmaceuticals - Endpoints News
Tarsus Pharmaceuticals, Inc. (TARS) Reports Q3 Loss, Beats Revenue Estimates - Yahoo Finance
Former Allergan CEO David Pyott joins Tarsus Pharmaceuticals board - Investing.com
Tarsus Pharmaceuticals Bets Big on XDEMVY Growth - TipRanks
8616 Tarsus Dr, Milton, FL 32583 - Realtor.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Tarsus Pharmaceuticals (NASDAQ:TARS) Shares Gap Up - Time to Buy? - MarketBeat
Eye drop drives $451M in sales as Tarsus tests pill to stop Lyme disease - Stock Titan
Tarsus Pharma COO Neervannan Seshadri sells $641k in stock - Investing.com
Tarsus Pharmaceuticals (NASDAQ:TARS) Downgraded to Hold Rating by Zacks Research - MarketBeat
Cherry Bekaert acquires Tarsus - Accounting Today
What both Paul of Tarsus and Lincoln encourage us to keep in mind regarding romantic love - Williamson Herald
Tarsus Pharmaceuticals (TARS): Losses Widen Despite Strong Growth Outlook, Challenging Bullish Narratives - Yahoo Finance
Tarsus Pharmaceuticals, Inc.'s (NASDAQ:TARS) Path To Profitability - Yahoo Finance
Cherry Bekaert acquires CPA outsourcing firm - Business North Carolina
Tarsus Pharmaceuticals at TD Cowen Conference: Eyeing Blockbuster Growth - Investing.com
Tarsus Pharmaceuticals (TARS) Narrowing EPS Loss Backs Bullish Earnings Turnaround Narrative - simplywall.st
Maker Of Eye Drops Has Sights On Buy Point - Investor's Business Daily
Tarsus Pharmaceuticals Appoints Renowned Biopharmaceutical Leader and Former Allergan CEO, David Pyott, to its Board of Directors - GlobeNewswire
Tarsus to Report Fourth Quarter and Full Year 2025 Financial Results on Monday, February 23, 2026 - GlobeNewswire
Tarsus to Participate in Upcoming Investor Conferences - Bitget
Tarsus (TARS) Q4 2025 Earnings Call Transcript - AOL.com
Tarsus Pharmaceuticals: Considering If The Big Marketing Push Will Pay Off (NASDAQ:TARS) - Seeking Alpha
Tarsus Pharmaceuticals: Making Big Strides (NASDAQ:TARS) - Seeking Alpha
Tarsus Pharmaceuticals (NASDAQ:TARS) Price Target Raised to $90.00 at Guggenheim - MarketBeat
Tarsus faces earnings test as losses narrow, revenue surges - Investing.com
Heritage on a plate: How EU support is helping to preserve Tarsus cuisine - EEAS
Foreign Language Equivalents
Foreign Language Equivalents of 'tarsus'
Language
Equivalent
Language
Equivalent
French
Spanish
Misspellings - Typos
tarsua, tarsuss, tarsys, tasrus, taesus, taraus, trasus, arsus, tsrsus, taruss, tardus, tarsis, tarrsus, tarssu, tarsud, tarus, tarsu, trsus, yarsus, tarssus, tasus, rarsus, atrsus, ttarsus, tatsus, tarss, tarsuus, taarsus
Words Starting with Letter - 'A'
a
a battery
a billion
a bit
a bit much
a capella singing
a cappella singing
a couple of
a few
a fortiori
a good deal
a great deal
a horizon
a hundred
a hundred and one
a hundred thousand
a hundred times
a kempis
a la carte
a la mode
a level
a little
a lot
a million
Go to Page 1
Go to Page 2 »
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z